Ikarian Capital, LLC - OCUPHIRE PHARMA INC ownership

OCUPHIRE PHARMA INC's ticker is OCUP and the CUSIP is 67577R102. A total of 32 filers reported holding OCUPHIRE PHARMA INC in Q3 2021. The put-call ratio across all filers is 1.11 and the average weighting 0.0%.

Quarter-by-quarter ownership
Ikarian Capital, LLC ownership history of OCUPHIRE PHARMA INC
ValueSharesWeighting
Q1 2022$401,000
-9.3%
124,021
+5.0%
0.05%
-19.7%
Q4 2021$442,000
-27.3%
118,0630.0%0.07%
+53.5%
Q3 2021$608,000
-3.8%
118,063
-1.2%
0.04%
-15.7%
Q2 2021$632,000
-8.8%
119,5510.0%0.05%
+121.7%
Q1 2021$693,000119,5510.02%
Other shareholders
OCUPHIRE PHARMA INC shareholders Q3 2021
NameSharesValueWeighting ↓
Richmond Brothers, Inc. 368,003$1,232,8122.32%
Knoll Capital Management, LLC 100,000$335,0000.35%
RICE HALL JAMES & ASSOCIATES, LLC 828,628$2,775,9040.18%
Diametric Capital, LP 56,059$187,7970.08%
THOMPSON DAVIS & CO., INC. 17,000$56,9500.07%
MAI Capital Management 455,677$1,526,5180.02%
TRUST CO OF TOLEDO NA /OH/ 30,963$103,7260.02%
BEDEL FINANCIAL CONSULTING INC 15,000$50,2500.01%
Legato Capital Management LLC 10,098$33,8280.01%
Stokes Family Office, LLC 13,030$43,6510.01%
View complete list of OCUPHIRE PHARMA INC shareholders